Ensuring people-centred diabetes care during the COVID-19 pandemic Experiences from Portugal (2020) (produced by WHO/Europe)

In anticipation of nationwide closures and movement restrictions even as the COVID-19 pandemic was in its early stages, Portugal rapidly rearranged services to ensure seamless diabetes care during the outbreak. The central government, among other measures, expedited the authorization of changes in clinical practice to allow teleconsultation and prescription medications to be distributed to patients’ homes. As of 29 May 2020, a total of 31 596 cases have been reported in Portugal.